Saturday, 10 October 2026European Markets
ExploreSearch
ViaNews EU
stock

FOUNTAIN Stock Bullish By 9% At Session Start Today

Loading stream...

(VIANEWS) - Shares of FOUNTAIN (BEL 20: FOU.BR) rose 9.35% to $1.17 at 10:55 EST on Tuesday, after five sequential sessions in a row of losses. BEL 20 is falling 0.65% to $3,863.83, after two consecutive sessions in a row of losses. This seems, at the moment, a somewhat bearish trend trading session today.

About FOUNTAIN

Fountain S.A. engages in the sale, rental, and provision of machines for cold and hot drinks made from freeze-dried or grain products in Europe. It provides coffee machines, water fountains, and cartridge machines for businesses. The company offers its products through independent distributors. Fountain S.A. was founded in 1972 and is headquartered in Braine-l'Alleud, Belgium.

Earnings Per Share

As for profitability, FOUNTAIN has a trailing twelve months EPS of $-0.143.

Volume

Today's last reported volume for FOUNTAIN is 750 which is 116.76% above its average volume of 346.

More news about FOUNTAIN (FOU.BR).

Categories

stock

Tags

FOU.BRStock PriceWall StreetMarket Session NowStock Market NowPrice UpMarket SessionStock Price UpFOUNTAINStock MarketStock
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Agentic Enterprise Software Consolidates: Big Platforms Push Autonomy While Startups Get Absorbed
Enterprise software is shifting toward autonomous, AI-agent-driven products. SAP (Autonomous Enterprise, Joule), Meta (a new Enterprise Platform led by ex-MongoDB CEO Chirantan Desai) and UiPath (raised guidance) are pushing from the top. Meanwhile AI-security and governance startups are being acquired (Fortinet–Virtue AI, Harvey–Guardrails AI, Tiny–Oso Cloud) and seed-stage agent companies keep raising capital (Dextr, Latitude, Groq). Investors such as Norwest's Sean Jacobsohn see finance and ERP back-office software as the easier area to disrupt. Trust and enforced governance are treated as preconditions for regulated sectors like finance, and AI is judged unreliable for calculations.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,366 source documents archived
Query this data → isubstrate.com